Home / Reviews
Early access

What early users say

Bacillus F is in limited early access, so this page is small and honest rather than padded. These are unedited comments from people running the protocol — and below them, an equally plain account of what we do not claim.

The voices

I came from three years of NMN. The documentation alone — patents, genome refs — is more than most brands ever show. That was what convinced me to try it, not the marketing.
MKMarkus K.Biohacker, Berlin
The permafrost story got my attention; the comet-assay data kept it. A refreshingly serious approach to a very noisy category. I appreciate that they publish what they have and stop there.
ASAiko S.Physician, Tokyo
Postbiotic, not live culture — a sensible, stable format. The drops fit into my morning protocol without any friction, and I did not have to reorganise a fridge shelf around them.
CLClaire L.Longevity researcher, Lyon
I run a quarterly biological-age panel. I started Bacillus F alongside the rest of my stack and I am treating it the way they suggest — baseline, ninety days, re-test. I like that they told me to do that instead of promising a number.
DRDaniel R.Founder, Austin
What I tell clients: the format is the strong part. A shelf-stable postbiotic removes the compliance problems live cultures create when someone travels.
HBHelena B.Nutritionist, Madrid

What we are not claiming

A testimonial is someone's impression. It is not evidence, and treating it as evidence is exactly the move that made this category untrustworthy in the first place. So, plainly:

  • None of these comments is a claim that Bacillus F treats, cures or prevents anything. It does not, and we do not offer it for that.
  • None of them is a measured outcome. Where someone mentions tracking a panel, that is their process, not a published result.
  • We do not publish before/after numbers from individuals. An n-of-1 change is not a finding.
  • We exclude, on principle, any testimonial touching serious illness — regardless of what the person says happened.

If you want something you can actually check, that is what the documentation archive is for.

Why there are no star ratings

Star ratings and “verified purchase” badges are trust signals that are trivially manufactured, and everyone knows it. Adding an aggregate rating to this page would also mean emitting review schema to search engines — asking Google to display a score built on a handful of early-access impressions.

We are not doing that. There is no AggregateRating markup anywhere on this site, by decision. When the product has enough genuine purchase history for a rating to mean something, we will revisit it — and say so when we do.

In the meantime the honest signals are the ones you can verify yourself: the organism, the patents, the registration and the safety documentation.

Questions about these accounts

No. They are unedited early-access comments, and we do not mark them up as verified reviews or emit review schema for them. Bacillus F is in limited early access, so this page is small rather than padded.

Deliberately. An aggregate rating on a handful of early-access impressions would give a number more authority than the underlying accounts can carry, so this site publishes none.

No. Nobody quoted here was paid, and several are practitioners who bought at full price.

No — read them as impressions. None is a measured outcome, none is a claim that the product treats, cures or prevents anything, and we publish no before/after numbers from individuals. The checkable material is the documentation archive on the Science page.

Judge it by the paperwork

Impressions are impressions. The documentation is the part you can check.

Open the evidenceRequest access